Physiological Mg2+ Conditions Significantly Alter the Inhibition of HIV-1 and HIV-2 Reverse Transcriptases by Nucleoside and Non-Nucleoside Inhibitors in Vitro

被引:8
作者
Achuthan, Vasudevan [1 ,2 ]
Singh, Kamlendra [3 ,4 ]
DeStefano, Jeffrey J. [1 ,2 ]
机构
[1] Univ Maryland, Cell Biol & Mol Genet, College Pk, MD 20742 USA
[2] Maryland Pathogen Res Inst, College Pk, MD 20742 USA
[3] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA
[4] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; DEPENDENT DNA-POLYMERASE; RNASE-H ACTIVITY; DRUG-RESISTANCE; 4'-ETHYNYL-2-FLUORO-2'-DEOXYADENOSINE EFDA; ANGSTROM RESOLUTION; SELECTIVE EXCISION; ACTIVE-SITE; MECHANISM; TYPE-1;
D O I
10.1021/acs.biochem.6b00943
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reverse transcriptases (RTs) are typically assayed in vitro with 5-10 mM Mg2+, whereas the free Mg2+ concentration in cells is much lower. Artificially high Mg2+ concentrations used in vitro can misrepresent different properties of human immunodeficiency virus (HIV) RT, including fidelity, catalysis, pausing, and RNase H activity. Here, we analyzed nucleoside (NRTIs) and non-nucleoside RT inhibitors (NNRTIs) in primer extension assays at different concentrations of free Mg2+. At low concentrations of Mg2+, NRTIs and dideoxynucleotides (AZTTP, ddCTP, ddGTP, and 3TCTP) inhibited HIV-1 and HIV-2 RT synthesis less efficiently than they did with large amounts of Mg2+, whereas inhibition by the "translocation-defective RT inhibitor" EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) was unaffected by Mg2+ concentrations. Steady-state kinetic analyses revealed that the reduced level of inhibition at low Mg2+ concentrations resulted from a 3-9-fold (depending on the particular nucleotide and inhibitor) less efficient incorporation (based on k(cat)/K-m) of these NRTIs under this condition compared to incorporation of natural dNTPs. In contrast, EFdATP was incorporated with an efficiency similar to that of its analogue dATP at low Mg2+ concentrations. Unlike NRTIs, NNRTIs (nevirapine, efavirenz, and rilviripine), were approximately 4-fold (based on IC50 values) more effective at low than at high Mg2+ concentrations. Drug-resistant HIV-1 RT mutants also displayed the Mg2+-dependent difference in susceptibility to NRTIs and NNRTIs. In summary, analyzing the efficiency of inhibitors under more physiologically relevant low-Mg2+ conditions yielded results dramatically different from those from measurements using commonly employed high-Mg2+ in vitro conditions. These results also emphasize differences in Mg2+ sensitivity between the translocation inhibitor EFdATP and other NRTIs.
引用
收藏
页码:33 / 46
页数:14
相关论文
共 78 条
  • [61] Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases
    Sarafianos, SG
    Das, K
    Hughes, SH
    Arnold, E
    [J]. CURRENT OPINION IN STRUCTURAL BIOLOGY, 2004, 14 (06) : 716 - 730
  • [62] Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition
    Sarafianos, Stefan G.
    Marchand, Bruno
    Das, Kalyan
    Himmel, Daniel M.
    Parniak, Michael A.
    Hughes, Stephen H.
    Arnold, Eddy
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2009, 385 (03) : 693 - 713
  • [63] Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence
    Schauer, Grant D.
    Huber, Kelly D.
    Leuba, Sanford H.
    Sluis-Cremer, Nicolas
    [J]. NUCLEIC ACIDS RESEARCH, 2014, 42 (18) : 11687 - 11696
  • [64] RNase H activity: Structure, specificity, and function in reverse transcription
    Schultz, Sharon J.
    Champoux, James J.
    [J]. VIRUS RESEARCH, 2008, 134 (1-2) : 86 - 103
  • [65] The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits
    Sevilya, Z
    Loya, S
    Hughes, SH
    Hizi, A
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2001, 311 (05) : 957 - 971
  • [66] Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase
    Singh, Kamalendra
    Marchand, Bruno
    Kirby, Karen A.
    Michailidis, Eleftherios
    Sarafianos, Stefan G.
    [J]. VIRUSES-BASEL, 2010, 2 (02): : 606 - 638
  • [67] MECHANISM OF INHIBITION OF HIV-1 REVERSE-TRANSCRIPTASE BY NONNUCLEOSIDE INHIBITORS
    SPENCE, RA
    KATI, WM
    ANDERSON, KS
    JOHNSON, KA
    [J]. SCIENCE, 1995, 267 (5200) : 988 - 993
  • [68] STARNES MC, 1989, J BIOL CHEM, V264, P7073
  • [69] Oral Administration of the Nucleoside EFdA (4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine) Provides Rapid Suppression of HIV Viremia in Humanized Mice and Favorable Pharmacokinetic Properties in Mice and the Rhesus Macaque
    Stoddart, Cheryl A.
    Galkina, Sofiya A.
    Joshi, Pheroze
    Kosikova, Galina
    Moreno, Mary E.
    Rivera, Jose M.
    Sloan, Barbara
    Reeve, Aaron B.
    Sarafianos, Stefan G.
    Murphey-Corb, Michael
    Parniak, Michael A.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (07) : 4190 - 4198
  • [70] Human immunodeficiency virus type 1 reverse transcriptase mutation selection during in vitro exposure to tenofovir alone or combined with abacavir or lamivudine
    Stone, C
    Ait-Khaled, M
    Craig, C
    Griffin, P
    Tisdale, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) : 1413 - 1415